Abstract
The occurrence of supraventricular tachycardia after high-dose intravenous methylprednisolone pulse therapy (HIVMPT) in a patient with active rheumatoid arthritis is described for the first time. This case report further expands the range of arrhythmias that can occur with HIVMPT. Other arrhythmias previously reported to occur after HIVMPT include atrial fibrillation, atrial flutter, junctional rhythm, and ventricular tachycardia. To the best of our knowledge, supraventricular tachycardia has not been reported previously, although severe bradycardia, hypotension, asystole, cardiovascular collapse, and sudden death have been documented. A review of the literature indicates that these case reports not withstanding, HIVMPT is generally safe, and cardiovascular toxicity is rare. However, close supervision with repeated measurements of blood pressure, electrocardiogram, and blood electrolytes is mandatory during and immediately after HIVMPT, especially for patients with pre-existing cardiovascular disease, and the lowest effective dose of methylprednisolone should be infused at a slow rate.
References
Arlet J (1984) Pulse corticoid therapy in rheumatology. Presse Med 13:1269–1271
Badsha H, Edwards CJ (2003) Intravenous pulses of methylprednisolone for systemic lupus erythematosus. Semin Arthritis Rheum 32:370–377
Baethge BA, Lidsky MD, Goldberg JW (1992) A study of adverse effects of high-dose intravenous (pulse) methylprednisolone therapy in patients with rheumatic disease. Ann Pharmacother 26:316–320
Miller JJ III (1980) Prolonged use of large intravenous steroid pulses in the rheumatic diseases of children. Pediatrics 65:989–994
Radia M, Furst DE (1988) Comparison of three pulse methylprednisolone regimens in the treatment of rheumatoid arthritis. J Rheumatol 15:242–246
Erstad BL (1989) Severe cardiovascular adverse effects in association with acute, high-dose corticosteroid administration. DICP 23:1019–1023
Garrett R, Paulus H (1980) Complications of intravenous methylprednisolone pulse therapy. Arthritis Rheum 23:677
Aslam AK, Vasavada BC, Sacchi TJ, Khan IA (2001) Atrial fibrillation associated with systemic lupus erythematosus and use of methylprednisolone. Am J Ther 8:303–305
Moretti R, Torre P, Antonello RM, Zorzon M, Cazzato G (2000) Recurrent atrial fibrillation associated with pulse administration of high doses of methylprednisolone: a possible prophylactic treatment. Eur J Neurol 7:130
McLuckie AE, Savage RW (1993) Atrial fibrillation following pulse methylprednisolone therapy in an adult. Chest 104:622–623
Ueda N, Yoshikawa T, Chihara M, Kawaguchi S, Niinomi Y, Yasaki T (1988) Atrial fibrillation following methylprednisolone pulse therapy. Pediatr Nephrol 2:29–31
Chikanza C, Fernandes L (1991) Arrhythmia after pulse methylprednisolone therapy. Br J Rheumatol 30:392–393
Guillen EL, Ruiz AM, Bugallo JB (1998) Hypotension, bradycardia, and asystole after high-dose intravenous methylprednisolone in a monitored patient. Am J Kidney Dis 32:E4
Belmonte MA, Cequiere A, Roig-Escofet D (1986) Severe ventricular arrhythmia after methylprednisolone pulse therapy in rheumatoid arthritis. J Rheumatol 13:477–479
Bocanegra TS, Castaneda MO, Espinoza LR, Vasey FB, Germain BF (1981) Sudden death after methylprednisolone pulse therapy. Ann Intern Med 95:122
Cohen IJ (1993) Cardiovascular collapse after high dose methylprednisolone. Pediatr Hematol Oncol 10:v-vii
Kucukosmanoglu O, Karabay A, Ozbarlas N, Noyan A, Anarat A (1998) Marked bradycardia due to pulsed and oral methylprednisolone therapy in a patient with rapidly progressive glomerulonephritis. Nephron 80:484
Moses RE, McCormick A, Nickey W (1981) Fatal arrhythmia after pulse methylprednisolone therapy. Ann Intern Med 95:781–782
Pudil R, Hrncir Z (2001) Severe bradycardia after a methylprednisolone “minipulse” treatment. Arch Intern Med 161:1778–1779
Schult M, Lohmann D, Knitsch W, Kuse ER, Nashan B (1999) Recurrent cardiocirculatory arrest after kidney transplantation related to intravenous methylprednisolone bolus therapy. Transplantation 67:1497–1498
Tvede N, Nielsen LP, Andersen V (1986) Bradycardia after high-dose intravenous methylprednisolone therapy. Scand J Rheumatol 15:302–304
Wollheim FA (1984) Acute and long-term complications of corticosteroid pulse therapy. Scand J Rheumatol Suppl 54:27–32
Liebling MR, Leib E, McLaughlin K, Blocka K, Furst DE, Nyman K, Paulus HE (1981) Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial. Ann Intern Med 94:21–26
Nasswetter G, Pineiro DJ, Garcia Morteo OM, Maldonado Cocco JA, Barreira JC, Vazquez BM (1984) Holter monitoring in ankylosing spondylitis patients during methylprednisolone pulse therapy. Clin Rheumatol 3:29–31
Sauerland S, Nagelschmidt M, Mallmann P, Neugebauer EA (2000) Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review. Drug Saf 23:449–461
Baethge BA, Lidsky MD (1986) Intractable hiccups associated with high-dose intravenous methylprednisolone therapy. Ann Intern Med 104:58–59
Fujimoto S, Kondoh H, Yamamoto Y, Hisanaga S, Tanaka K (1990) Holter electrocardiogram monitoring in nephrotic patients during methylprednisolone pulse therapy. Am J Nephrol 10:231–236
Ozen S, Tokgozoglu L, Saatci U (1992) Are late potentials operative in arrhythmias following methylprednisolone pulse therapy. Int J Cardiol 36:234–235
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumari, R., Uppal, S.S. First report of supraventricular tachycardia after intravenous pulse methylprednisolone therapy, with a brief review of the literature. Rheumatol Int 26, 70–73 (2005). https://doi.org/10.1007/s00296-005-0589-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-005-0589-7